Innovation

VUMC joins group to accelerate implementation of research findings to improve patient outcomes

Vanderbilt University Medical Center is part of a select group of health systems nationwide brought together to accelerate the implementation of medical research results that will improve patient outcomes.

VUMC’s new automated biobanking system can store as many as 10 million biospecimens.

Nashville Biosciences and Illumina announce sequencing agreement with Amgen

Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center, and Illumina Inc., a global leader in DNA sequencing and array-based technologies, today announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence approximately 35,000 DNA samples.

‘DNA’ Podcast Hosts Two Climate and Health Twitter Spaces Chats

Climate and Health conversations will take place on Nov. 13 and 14, from 12:15 pm – 1 pm CT on Twitter Spaces.

Kristy Sinkfield, MEd, left, hosted a panel discussion with Mamie Williams, MPH, MSN, FNP-BC, Mary Duvanich, MSN, MMHC, Novonda Lilly, and Marques Bradshaw, MD, during Strategy Share 2022. The discussion was on promoting diversity, equity and inclusion throughout VUMC. (photo by Erin O. Smith)

Strategy Share 2022 spotlights VUMC’s successes in making health care personal

Strategy Share 2022 was centered on initiatives and programs that advance the three components of the Medical Center’s Strategic Directions: Making Diversity and Inclusion Intentional, Design for Patients and Families, and Discover, Learn and Share.

VUMC to lead AI ethics core for NIH project

Vanderbilt researchers will lead and comprise the greater part of an artificial intelligence research ethics core for a National Institutes of Health (NIH) program called Bridge to Artificial Intelligence, or Bridge2AI.

Study tests drug to illuminate cancer during surgery

A Vanderbilt study is testing drugs that provide a targeted fluorescent dye that clings to and illuminates cancer.

1 2 3 4 5 6